Annexon

Annexon Diluted EPS

The Diluted Earnings per Share of Annexon (ANNX) as of Nov 3, 2026 is -1.33 USD. In the previous year, Diluted Earnings per Share was -0.93 USD — a change of 42.53% (lower).

Diluted EPS

-1.33USD

YoY

42.53%

Last updated:

Diluted Earnings per Share of Annexon is 2025 -1.33 USD. Diluted Earnings per Share of Annexon was 2024 -0.93 USD. It decreases by 42.53% lower compared to the previous year.

The Annexon Diluted EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Diluted EPS
Date
Diluted EPS
Jan 1, 2018
-42.31 USD
Jan 1, 2019
-2.83 USD
Jan 1, 2020
-1.64 USD
Jan 1, 2021
-3.32 USD
Jan 1, 2022
-1.91 USD
Jan 1, 2023
-1.72 USD
Jan 1, 2024
-0.93 USD
Jan 1, 2025
-1.33 USD
The Annexon Diluted EPS history
YEARDiluted EPSYoY
-1.33USD+42.53%
-0.93USD-45.52%
-1.72USD-10.19%
-1.91USD-42.46%
-3.32USD+101.97%
-1.64USD-41.99%
-2.83USD-93.30%
-42.31USD+8,544.43%
-0.49USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Annexon Stock analysis

What does Annexon do? Annexon Inc is a biopharmaceutical company based in South San Francisco, California. It was founded in 2011 by Doug Love, Ted Love, and Arnon Rosenthal, who had previously worked at major pharmaceutical companies such as Genentech and Novartis. The company's main goal is to develop new treatment options for neurodegenerative diseases, focusing on the development of drugs that target the autophagy process in cells to reduce damage to nerve cells and alleviate symptoms. Annexon Inc has two divisions, Annexon Biosciences and Annexon Clinical, with partnerships with renowned pharmaceutical companies to advance drug development. Its main product is ANX005, a therapeutic antibody protein that targets the role of the complement system in neurodegenerative diseases. Annexon Inc has received multiple awards for its work and innovations and has a dedicated team of scientists and executives committed to improving the lives of people with neurodegenerative diseases. Annexon is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Annexon stock

Diluted Earnings per Share of Annexon is -1.33 USD in 2025.

Diluted Earnings per Share of Annexon changed from -0.93 USD to -1.33 USD, representing a 42.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share Annexon since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Annexon

All Key Metrics — Annexon